Metoprolol succinate and Hallucination, visual - a phase IV clinical study of FDA data

Summary:

Hallucination, visual is reported as a side effect among people who take Metoprolol succinate (metoprolol succinate), especially for people who are female, 60+ old, have been taking the drug for 6 - 12 months also take Nuplazid, and have Parkinson's disease.

The phase IV clinical study analyzes which people have Hallucination, visual when taking Metoprolol succinate. It is created by eHealthMe based on reports of 64,247 people who have side effects when taking Metoprolol succinate from the FDA, and is updated regularly.

What is Metoprolol succinate?

Metoprolol succinate has active ingredients of metoprolol succinate. It is often used in high blood pressure. eHealthMe is studying from 66,933 Metoprolol succinate users. Check the latest studies of Metoprolol succinate.

What is Hallucination, visual?

Hallucination, visual (seeing things that aren't there) is found to be associated with 1,061 drugs and 1,370 conditions by eHealthMe. Check the latest studies of Hallucination, visual.

On Jul, 19, 2026

64,247 people reported to have side effects when taking Metoprolol succinate.
Among them, 138 people (0.21%) have Hallucination, visual.

Could Metoprolol succinate cause Hallucination, visual?

Among these 138 people:

How long have people been on Metoprolol succinate when they have Hallucination, visual? *

Click here to view more results

What is the gender of people who have Hallucination, visual when taking Metoprolol succinate? *

Click here to view

What is the age of people who have Hallucination, visual when taking Metoprolol succinate? *

Click here to view more results

* Approximation only. Some reports may have incomplete information.

Do you take Metoprolol succinate and have Hallucination, visual?

- Check whether Hallucination, visual is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Metoprolol succinate:

Metoprolol succinate (66,933 reports)

Hallucination, visual treatments and more:

Hallucination, visual (24,013 reports)

How severe was Hallucination, visual and when was it recovered:

Hallucination, visual in Metoprolol succinate

Expand to all the drugs that have ingredients of metoprolol succinate:

Hallucination, visual and drugs with ingredients of metoprolol succinate (839 reports)

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Metoprolol succinate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hallucination, visual:

Hallucination, visual (1,061 drugs)

Browse all the conditions that are associated with Hallucination, visual:

Hallucination, visual (1,370 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on metoprolol succinate (the active ingredients of Metoprolol succinate) and Metoprolol succinate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.